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ABSTRACT. Polycystic ovary syndrome is the classic example of 
loss of functional cyclicity and anomalous feedback. In this case, the 
excessive extra-glandular production and conversion of androgens to 
estrogens are the pathophysiological basis of the chronic anovulation. 
The literature describes an experimental model of the polymicrocystic 
ovary in obese diabetic mice with insulin resistance. The fact that these 
animals exhibit obesity, insulin resistance, and infertility demonstrates 
their skill as an experimental model for polycystic ovary. A recent study 
using long protocol for up to 40 weeks showed that anovulatory and 
obese mice transplanted with adipose tissue from animals with normal 
weight have multiple changes in their phenotype. These changes 
include reduction of body weight, prevention of obesity, insulin level 
normalization, and insulin tolerance tests, preventing the elevation 
of steroids and especially the reversal of fertility restoration with 
anovulation. Considering that there are close relationships between 
the ovulation process and the central nervous system, we propose to 
evaluate the gene expression levels of 84 different genes involved in 
neurotransmission and insulin pathways in addition to examining the 
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neurolipidosis differential murine brain before and after reversal of 
anovulation. The present study showed changes in gene expression of 
molecular markers in brain tissue of animals for brain neurotransmission 
pathways as well as pathways for insulin. GABAergic genes, 
muscarinic, serotonin receptors, receptor tyrosine kinase, and genes of 
interleukin 6 showed overexpression profile. There was also a change 
in the lipid content in anovulatory brain, obesity, and insulin resistant 
mice (Ob-/Ob-) compared with controls. The re-introduction of leptin 
in these animals appears to reverse, at least in part, this profile.
Key words: Differentially expressed genes; Neurotransmitter; Anovulation
INTRODUCTION
Polycystic ovary syndrome (PCOS) is one of the most frequent observed endocrinopathies 
of women during their reproductive age, and it is estimated to affect 6.8% of them (Diamanti-
Kandarakis et al., 1999). Different from the previous hypothesis, PCOS seems now to be 
more related to insulin resistance rather than to the initially regarded as hyperandrogenism in 
reproductive age. Indeed, the insulin resistance and hyperinsulinemia participate in reproductive 
as well as metabolic disturbances associated with PCOS (Diamanti-Kandarakis, 2008). 
Implications may even extend beyond the reproductive axis, creating a need for a modified 
therapeutic management of affected women, especially from the cardiovascular point-of-view.
Another hallmark of the syndrome is a high GnRH pulse frequency resulting in 
elevated LH levels and LH/FSH ratio stimulating ovarian androgen production. It has been 
demonstrated that these women have decreased hypothalamic sensitivity to progesterone-
mediated feedback, in addition to reduced luteal phase progesterone production resulting from 
frequent anovulatory cycles. This effect is mediated by androgens and aggravated by insulin 
resistance (Blanksby and Mitchell, 2010).
In animal models, a similar reproductive endocrine phenotype occurs when the Leptin 
gene is knockdown. Despite the well-known fact that the central nervous system plays a major 
role in PCOS, very little is known about the specific molecular events that take place inside 
the brain during the anovulatory process and metabolic syndrome.
Therefore, in the present article, our aim was to analyze the expression of 84 genes 
involved in modulating the biological processes of neurotransmitter biosynthesis, uptake, 
transport, and signaling through brain neurotransmitter receptors of female obese, insulin-
resistant, non-ovulating, leptin-deficient (Ob/Ob) mice. Neurotransmission gene expression 
was further analyzed in the brain after the re-introduction of leptin in these animals.
MATERIAL AND METHODS
In vivo murine studies
Six-week-old female obese ob/ob mice together with their lean littermate controls were 
used. All procedures were approved by the Federal University of São Paulo Institutional Animal 
Care and Use Committee. Animals were housed with ad libitum access to food and water.
All animals were maintained in a temperature-controlled environment at ±24°C under 
a 12:12-h light-dark cycle and handled at least one time per week. Diet was a regular chow 
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(F6 Rodent Diet; Harlan Teklad, Madison, WI, USA) comprised of 52% carbohydrate, 18% fat, 
and 31% protein by calorie or KD (F-3666; Bio-Serv, Frenchtown, NJ, USA) comprised of 0.4% 
carbohydrate, 95% fat, and 4.5% protein by calorie. Animal groups were divided as follows: 1- 
Control group (CG): Composed of 5 normal weight, 2 to 3 months of age B6.V-Lepob/J mice. 
After sacrifice brains were removed and kept in liquid nitrogen until use. 2- Obesity group (OG): 
Composed of 5 overweight, anovulatory, 2 to 3 months of age B6.V-Lepob/J mice. After sacrifice 
brains were removed and kept in liquid nitrogen until use. 3- Obesity group transplanted (OGT): 
Composed of 5 overweight, anovulatory, 2 to 3 months of age B6.V-Lepob/J mice that were 
recipient to fat transplantation from ovulating mice and sacrificed after 7 days of transplant. After 
sacrifice brains were removed and kept in liquid nitrogen until use.
Fat tissue transplant
Five female leptin-deficient (B6.V-Lepob/J, referred to as ob/ob) mice and their lean 
littermates were obtained from the animal facility of our University. A group of ob/ob mice 
received fat tissue transplantation as described by Gavrilova et al. (2000). Briefly, gonadal fat 
from wild-type littermates euthanized by cervical dislocation was placed in sterile PBS and 
cut into small pieces. The grafts were implanted subcutaneously through small incisions in the 
shaved skin of the back of recipient ob/ob mice anesthetized with isoflurane.
Approximately 1 g tissue was transplanted per mouse. Incisions were closed using 
wound clips and mice observed for wound closure. The second group of ob/ob mice was 
sham-operated. Mice were observed for 7 days after transplant, at which point they were 
sacrificed by cervical dislocation under isoflurane anesthesia.
RT profiler PCR-array mouse neurotransmitter receptors and regulators
The Mouse Neurotransmitter Receptors and Regulators RT2 ProfilerTM PCR Array, 
containing 84 genes involved in neurotransmission, was applied and run in triplicates together with 
five housekeeping genes (18srRNA, HPRT1, RPL13A, GAPD, and ACTB). Whole mouse brain was 
subjected to RNA extraction, cDNA synthesis, and PCR array as recommended by the manufacturer.
The amount of total RNA was quantified in ng/µL using the Nanodrop device. Gel 
electrophoresis of selected samples was performed on denaturating 2.0% agarose gel containing 
ethidium bromide and revealed the two rRNA bands corresponding to 28S and 18S. Sample purity 
was determined by calculating the 260/280 ratios and found within the 1.6 to 2.2 range in all samples.
The samples were stored at -80°C and cDNA was obtained by using the Reaction 
ReadyTM First-Strand cDNA Synthesis Kit (SuperArray), and the procedures were performed 
following the manufacturer’s instructions.
Negative control for genomic DNA and contaminating RNA were also conducted 
in each sample. Amplification, data acquisition, and the melting curve were carried out by 
iCycler iQ (Bio-Rad Laboratories, Hercules, CA, USA). The Ct and the melting curve of every 
gene were observed for every animal.
The threshold to determine the Ct value for each gene was automatically established 
by the iCycler iQ version 3 software that determined the SD of the points forming the baseline. 
Results are reported as Ct and normalized with the housekeeping gene 18SrRNA. The fold-
change ratio for each gene was compared between the brain anovulatory groups and healthy 
mice counterparts. Analysis of variance followed by the Dunnett post hoc multiple comparison 
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tests was used to compare the Ct results generated by the RT Profiler PCR Array between 
anovulatory groups against the control group. Genes are reported as differently expressed 
between groups when the fold-change was at least three-fold up-regulated or down-regulated, 
and the P value (analysis of variance and post-test) was lower than or equal to 0.05.
Neurotransmitter receptors analyzed
Acetylcholine Receptors: Anxa9, Chrm3.
Muscarinic Acetylcholine Receptors: Chrm1, Chrm2, Chrm3, Chrm4, Chrm5.
Adrenocorticotropin Receptors: Mc2r.
Bombesin Receptors: Brs3, Grpr.
Cholecystokinin Receptors: Cckar, Cckbr.
Dopamine Receptors: Drd1a, Drd2, Drd3, Drd4, Drd5.
GABA-A Receptors: Gabra1, Gabra2, Gabra3, Gabra4, Gabra5, Gabra6, Gabrb2, 
Gabrb3, Gabrd, Gabrg1, Gabrg2, Gabrp, Gabrq, Gabrr1, Gabrr2, Glra1, Glra2, Glra3, Glra4.
Gastrin Receptors: Cckar, Cckbr, Galr1, Galr2, Galr3.
Neuromedin U Receptors: Nmur1, Nmur2.
Neuropeptide Receptors: Npffr1 (Gpr147), Npffr2 (Gpr74), Ntsr1.
Neuropeptide Y Receptors: Gpr103, Prokr1 (Gpr73), Prokr2 (Gpr73l1), Gpr83, 
Npy1r, Npy2r, Npy5r, Npy6r, Pgr15l, Ppyr1, Prlhr (Gpr10).
Peptide YY Receptors: Npy1r, Npy2r, Npy5r, Npy6r, Ppyr1.
Somatostatin Receptors: Sstr1, Sstr2, Sstr3, Sstr4, Sstr5.
Tachykinin Receptors: Tacr1, Tacr2, Tacr3.
Other Neurotransmitter Receptors: Chrna1, Chrna2, Chrna3, Chrna4, Chrna5, 
Chrna6, Chrna7, Chrnb1, Chrnb2, Chrnb3, Chrnb4, Chrnd, Chrne, Chrng, Glrb, Htr3a.
Regulation of neurotransmitter levels
Neurotransmitter Biosynthesis: Chat, Gad1, Slc5a7
Neurotransmitter Catabolism: Ache, Comt, Maoa.
Immunohistochemistry
To further confirm our results and also identify the localization of protein expression 
in the brain, immunohistochemistry was also performed for the most up-regulated genes, 
Gabrb3 and Gabrg2.
RESULTS
Among the 84 genes studied between the brain of normal and obese mice, we 
identified 34 as differentially expressed after statistical analysis. Of that, 13 were considered 
down-regulated and 21 up-regulated (Table 1). Remarkably, after only 7 days of the fat tissue 
transplant, only one gene, Tacr3, remained up-regulated in the brain of the transplanted group.
A gene expression analysis was performed for all the genes described before and 
after transplantation, it was possible to notice that the great majority of the genes presented 
were hyperexpressed (Figure 1) at the moment before transplantation and after 7 days of the 
Transplantation, it was possible to identify a notable reversal of this characteristic (Figure 2).
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Table 1. Gene expression level in of the brain analysis of anovulatory mice.
Functional gene groupings Obese mice fold- 
change
P value 7 days of transplant P value 
Neurotransmitter Receptors 
Acetylcholine Receptors 
Anxa9 -4.11 0.020670 -9.32 0.000062 
Chrm3 -1.79 0.974012 -7.57 0.000000 
Muscarinic Acetylcholine Receptors 
Chrm1 48.84 0.091955 -3.07 0.000211 
Chrm2 2.66 0.150482 -2.10 0.001728 
Chrm3 -1.79 0.974012 -7.57 0.000000 
Chrm4 1.69 0.214442 -2.58 0.001921 
Chrm5 1.08 0.370781 -2.17 0.006942 
Adrenocorticotropin Receptors 
Mc2r -3.34 0.068337 -3.07 0.000145 
Bombesin Receptors 
Brs3 -6.92 0.023793 -3.07 0.016254 
Grpr -2.53 0.708941 -2.50 0.000156 
Cholecystokinin Receptors 
Cckar -4.56 0.051037 -5.74 0.007709 
Cckbr -1.03 0.427239 -4.66 0.003998 
Dopamine Receptors 
Drd1a -1.31 0.688211 -6.59 0.000385 
Drd2 -1.31 0.712160 -5.17 0.002160 
Drd3 -1.18 0.575474 -1.48 0.225068 
Drd4 -2.53 0.394967 -10.34 0.000607 
Drd5 -4.11 0.116153 -6.36 0.000010 
GABA-A Receptors 
Gabra1 58.08 0.079586 -4.20 0.000085 
Gabra2 3.05 0.142180 -2.68 0.003229 
Gabra3 17.27 0.102259 1.44 0.750036 
Gabra4 20.53 0.121194 -1.54 0.255686 
Gabra5 8.06 0.100040 -5.94 0.005289 
Gabra6 5.13 0.120686 -14.12 0.000000 
Gabrb2 22.78 0.095446 -5.54 0.003224 
Gabrb3 232.32 0.070995 -2.97 0.000424 
Gabrd 2.16 0.170917 -5.74 0.000006 
Gabrg1 3.76 0.267210 1.26 0.403649 
Gabrg2 164.28 0.071247 -1.09 0.443929 
Gabrp 1.16 0.333973 -3.41 0.000438 
Gabrq -1.79 0.967364 -3.18 0.005660 
Gabrr1 -2.62 0.444059 -2.58 0.100276 
Gabrr2 -1.56 0.651516 -2.97 0.006893 
Glra1 -2.53 0.479330 -2.50 0.117328 
Glra2 -2.13 0.602807 -2.87 0.006055 
Glra3 3.89 0.115340 -1.09 0.700959 
Glra4 -2.62 0.665324 -3.41 0.022184 
Gastrin Receptors 
Cckar -4.56 0.051037 -5.74 0.007709 
Cckbr -1.03 0.427239 -4.66 0.003998 
Galr1 -4.72 0.016241 -5.74 0.000000 
Galr2 -2.81 0.304981 -2.87 0.148685 
Galr3 -2.71 0.260494 -1.13 0.301424 
Neuromedin U Receptors 
Nmur1 -1.36 0.487064 -3.41 0.005531 
Nmur2 -1.79 0.953509 -3.07 0.000493 
Neuropeptide Receptors 
Npffr1 (Gpr147) -2.13 0.840610 -8.69 0.000004 
Npffr2 (Gpr74) 1.47 0.230477 -1.96 0.002482 
Ntsr1 1.16 0.292900 -2.03 0.019582 
Neuropetide Y Receptors 
Qrfpr 4.32 0.067335 -1.16 0.357521 
Prokr1 (Gpr73) -3.84 0.170310 -2.41 0.095515 
Prokr2 (Gpr7311) -1.99 0.833335 -1.09 0.468912 
Gpr83 1.88 0.190744 -7.06 0.000002 
Npy1r 1.64 0.239341 -1.83 0.046601 
Npy2r 1.53 0.251263 -1.54 0.054869 
Continued on next page
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Npy5r 10.27 0.097446 -2.03 0.000747 
Npy6r -3.23 0.276981 -4.66 0.015249 
Pgr15l 1.58 0.225764 1.21 0.114330 
Ppyr1 -2.20 0.609688 -3.41 0.001583 
Prlhr (Gpr10) -1.79 0.945939 -3.18 0.004313 
Peptide YY Receptors 
Npy1r 1.64 0.239341 -1.83 0.046601 
Npy2r 1.53 0.251263 -1.54 0.054869 
Npy5r 10.27 0.097446 -2.03 0.000747 
Npy6r -3.23 0.276981 -4.66 0.015249 
Ppyr1 -2.20 0.609688 -3.41 0.001583 
Somatostatin Receptors 
Sstr1 -1.31 0.888664 -1.09 0.499841 
Sstr2 11.39 0.120448 -1.83 0.182661 
Sstr3 -3.01 0.629782 -5.35 0.000059 
Sstr4 2.08 0.889827 -1.43 0.214445 
Sstr5 2.16 0.174080 -1.16 0.357521 
Tachykinin Receptors 
Tacr1 -2.36 0.844945 -2.41 0.002405 
Tacr2 -6.23 0.010367 -11.47 0.001098 
Tacr3 14.03 0.109652 4.53 0.026174 
Other Neurotransmitter Receptors 
Chrna1 -6.92 0.001124 -7.06 0.000001 
Chrna2 2.01 0.436780 -2.33 0.170204 
Chrna3 -1.27 0.579056 -9.65 0.000013 
Chrna4 2.23 0.182199 -4.50 0.022366 
Chrna5 -4.89 0.066526 -2.41 0.078253 
Chrna6 -2.36 0.552564 -2.97 0.000157 
Chrna7 -3.23 0.328895 -3.18 0.047374 
Chrnb1 -3.58 0.162537 -1.96 0.113367 
Chrnb2 8.34 0.173478 1.26 0.326259 
Chrnb3 -2.81 0.310689 -1.89 0.101501 
Chrnb4 -3.97 0.123375 -7.84 0.000201 
Chrnd 4.96 0.124909 -1.25 0.166996 
Chrne -15.35 0.015633 -10.70 0.013186 
Chrng -1.99 0.823609 -2.25 0.028641 
Glrb 94.35 0.066486 1.49 0.538925 
Htr3a -4.26 0.175870 -2.87 0.089983 
Regulation of Neurotransmitter Levels 
Neurotransmitter Biosynthesis 
Chat -1.14 0.656465 -2.87 0.040200 
Gad1 27.10 0.086453 -2.33 0.093293 
Slc5a7 4.63 0.167870 1.26 0.493606 
Neurotransmitter Catabolism 
Ache 2.08 0.181419 -2.97 0.000575 
Comt -1.40 0.979578 -6.36 0.000836 
Maoa 3.51 0.108982 -2.68 0.002493 
Table 1. Continued.
Immunohistochemistry analysis
The results obtained in the immunohistochemical tests confirmed the molecular 
findings by using antibodies specific for the differentially expressed genes found in brain 
tissue of mice (Figures 3 and 4); it is possible to verify the presence of specific large-scale 
brain tissue antibodies.
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Figure 1. Gene expression in brain before transplantation.
Figure 2. Gene expression in brain after 7 days of fat tissue transplantation.
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Figure 3. A. Anti- Gabrg2. B. Anti- Gabrg2 (Increased A: 200X; B: 400X).
Figure 4. A. Anti-Gabrb3. B. Anti-Gabrb3 (Increased A: 200X; B: 400X).
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DISCUSSION
In the present article, we were able to identify aberrant expression of genes in the 
brain of female obese, insulin-resistant, non-ovulating mice. Indeed, after analyzing 84 genes 
involved in modulating biological processes such as neurotransmitter biosynthesis, uptake, 
transport, and signaling we identified, after a triplicate real-time PCR confirmation, a total of 
34 genes whose expression were found altered in the brain from anovulatory animals.
Among these genes, the GABA-A receptors were the most abundant up-regulated 
category responding for 32.2% (11 of 34 genes) of all differentially expressed genes. The 
second more abundantly affected category of neurotransmitter receptors, in anovulatory 
brains, was the Cholinergic Receptors Nicotinic (CHRN) accounting for 20.5% (7 of 34 genes) 
of all abnormally expressed genes. The third more commonly misbalanced group of genes 
was the one involved in coding the Neuropeptide Y Receptors responding for 11.7% (4 of 34 
genes) of all differentially expressed genes. The other 12 misbalanced genes were scattered in 
other classes displayed in Table 1.
It is well known that the feedback regulation of GnRH neurons by steroid hormones 
is critical to normal reproductive function and occurs in part through altered GABAergic drive 
to these cells (Qublan and Malkawi, 2005; Zafar, 2005; Rouzi et al., 2006; Freret et al., 2006; 
Costello et al., 2007a,b). Altered sensitivity to steroid feedback is associated with forms of 
hypothalamic infertility such as the common reproductive disorder PCOS, a leading cause of 
infertility in women.
Indeed, in the present study, we were able to show that in our model of anovulation, 
obesity and insulin resistance, the lack of leptin was followed by a remarkable up-regulation 
of GABA-A mRNA receptors that was completely normalized after only 7 days of leptin 
introduction.
This finding suggests that the GABAergic system may play a role in forms of 
hypothalamic infertility; however, there is some controversy on whether the GABAergic 
activity, a known inhibitory pathway, can inhibit GnRH neurons.
GABA inhibits most mature neurons, but this is controversial for GnRH neurons. In 
fact, GnRH neurons maintain elevated chloride (Chehab et al., 1996), as do other neurons 
derived from olfactory placode (Mounzih et al., 1997), and may thus be excited by GABA-A 
receptor activation. Studies using functional approaches to examine GnRH neurons differ as 
to whether GABA excites or inhibits these neurons (Chehab et al., 1996; Mounzih et al., 1997; 
Farooqi et al., 2002; Oral et al., 2002), but direct correlations between reduced fertility and 
reduced GABAergic drive support the former (Zhang et al., 1994; Schubring et al., 1997). 
Regardless of the response of GnRH neurons to GABAAR activation, GABAARs clearly play 
a role in fertility regulation.
The different actions of acetylcholine (ACh) are mediated by activation of nicotinic 
(ionotropic) and muscarinic (metabotropic) classes of receptors. Nicotinic receptors (nAChRs) are 
ligand-gated receptor channels that are cation-specific but do not distinguish readily among cations 
(Edman and MacDonald, 1978). Both classes of cholinergic receptors are expressed throughout 
the brain and are abundant in the hypothalamus, where monoaminergic neurons that terminate 
on GnRH and other peptidergic neurons are located (Goldzieherand Green, 1962). The GnRH 
neurons of the hypothalamus are innervated by noradrenergic neurons located in the hindbrain, 
and catecholamines have been implicated in the regulation of GnRH release. In contrast, there is 
less evidence for a role of cholinergic innervation in the control of GnRH secretion.
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